PP
BLUE

PFS Partners’s bluebird bio BLUE Stock Holding History

PFS Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17
Closed -$177 – 449
2024
Q3 		$177 Hold
17
– – ﹤0.01% 439
2024
Q2 		$335 Hold
17
– – ﹤0.01% 418
2024
Q1 		$436 Hold
17
– – ﹤0.01% 439
2023
Q4 		$470 Hold
17
– – ﹤0.01% 434
2023
Q3 		$1.03K Hold
17
– – ﹤0.01% 428
2023
Q2 		$1.12K Hold
17
– – ﹤0.01% 443
2023
Q1 		$1.08K Hold
17
– – ﹤0.01% 357
2022
Q4 		$2.35K Buy
+17
New +$2.4K ﹤0.01% 309

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PFS Partners's BLUE Position: Q4 2024 in Review

PFS Partners sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 17 shares — an estimated $177 sold.

PFS Partners first reported a position in BLUE in Q4 2022 and held it in 8 quarters. The position peaked at $2.35K in Q4 2022. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • PFS Partners reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • PFS Partners sold 17 bluebird bio shares in Q4 2024, an estimated $177.
  • PFS Partners first reported a position in bluebird bio in Q4 2022 and held it in 8 quarters.
  • PFS Partners's bluebird bio position peaked at $2.35K in Q4 2022.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on PFS Partners's 13F filing for Q4 2024, filed 27 Jan 2025.